Ellen Beausang - Mar 31, 2025 Form 4 Insider Report for Aspira Women's Health Inc. (AWH)

Role
Director
Signature
/s/ Ellen Beausang
Stock symbol
AWH
Transactions as of
Mar 31, 2025
Transactions value $
$0
Form type
4
Date filed
4/1/2025, 08:59 PM
Previous filing
Apr 1, 2025
Next filing
Jun 5, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AWH Common Stock Options Exercise $0 +1.62K $0.00 1.62K Mar 31, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AWH Restricted Stock Units Options Exercise $0 -1.62K -25.01% $0.00 4.84K Mar 31, 2025 Common Stock 1.62K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the conversion upon vesting of restricted stock units (RSUs) into common stock. On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. Such RSUs were previously reported in Table II on a Form 4 filed with the SEC on April 1, 2025.
F2 Each restricted stock unit is the economic equivalent of one share of Aspira Women's Health Inc. Stock
F3 On March 11, 2025, the reporting person was granted 6,458 RSUs, 1,615 of which vested on March 31, 2025. The common stock into which such vested RSUs converted on March 31, 2025 is reported in Table I on this Form 4.